Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The purpose of this study is to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of M254 after administration of a single ascending dose and repeat doses in healthy volunteers and immune thrombocytopenic purpura (ITP) patients. The pharmacodynamics of the drug will be measured as platelet response in patients with ITP.
Epistemonikos ID: 62abb7dcf3f1f77cbc92575656b04c058d297d93
First added on: May 22, 2024